Related Experiment Video
Updated: Jul 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang1, Cong S Zong, Weiya Xia
1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
The RAS-ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that Erk downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylated FOXO3a degrades via an MDM2-mediated ubiquitin-proteasome pathway. However, the non-phosphorylated FOXO3a mutant is resistant to the interaction and degradation by murine double minute 2 (MDM2), thereby resulting in a strong inhibition of cell proliferation and tumorigenicity. Taken together, our study elucidates a novel pathway in cell growth and tumorigenesis through negative regulation of FOXO3a by RAS-ERK and MDM2.
Insights
The RAS-ERK pathway promotes tumor growth by phosphorylating and degrading FOXO3a via MDM2. A non-phosphorylated FOXO3a mutant inhibits proliferation, revealing a novel cancer pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The RAS-ERK pathway is crucial for cell differentiation, proliferation, and tumor progression.
- Dysregulation of this pathway is implicated in various cancers.
Purpose of the Study:
- To elucidate the molecular mechanism by which the RAS-ERK pathway regulates Forkhead box O 3a (FOXO3a).
- To investigate the role of FOXO3a phosphorylation and degradation in tumorigenesis.
Main Methods:
- Direct interaction and phosphorylation assays to study Erk and FOXO3a.
- MDM2-mediated degradation studies using wild-type and mutant FOXO3a.
- Cell proliferation and tumorigenicity assays.
Main Results:
- Erk directly phosphorylates FOXO3a at specific serine residues (Ser294, Ser344, Ser425).
- Phosphorylated FOXO3a undergoes MDM2-mediated degradation, promoting cell proliferation and tumorigenesis.
- A non-phosphorylated FOXO3a mutant resists MDM2 interaction and degradation, inhibiting cell proliferation and tumorigenicity.
Conclusions:
- The RAS-ERK pathway negatively regulates FOXO3a stability and function.
- This novel pathway involving RAS-ERK, FOXO3a, and MDM2 is critical for controlling cell growth and tumorigenesis.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
